Using next generation sequencing to identify cancer mutations in Asian populations
Singapore General Hospital (SGH) and Thermo Fisher Scientific will collaborate to identify cancer genetic mutations linked with Asian populations on Thermo Fisher’s Ion Torrent next-generation sequencing (NGS) platform. Phased approaches will be used to analyse retrospective samples from cancer patients with Asian ancestry to identify the mutational profiles and their differences from existing data of reference populations.
NCCS conducts clinical trials for immunotherapy
A team of researchers from the National Cancer Centre Singapore (NCCS) is conducting clinical trial that uses immunotherapy to fight advanced nasopharyngeal or nose cancer. Through this, the patient's own immune system is used to fight the cancer cells. The NCCS team will be conducting a phase 3 trial for advanced nose cancer, the first to be undertaken in the world. More than 300 patients, from Singapore and beyond, will be recruited for the trial. replace.Singaporeresearchersidentifynewdeadlycancer.aspx